PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Proprietary compound preparation BNF 0905011
Presentation Product Chemical substance Chapter Items dispensed
Calvive 1000 effervescent tablets
090501100BBCBAD
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood 3,648
Alliance Calcium syrup
090501100BBFRAY
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood 142
Boots Calcium 266.6mg chewable tablets
090501100BBEBA0
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood No data available
Calcium-Sandoz syrup
090501100BBAAAW
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood No data available
HealthAid Magnesium & Calcium tablets
090501100BBBGA0
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood No data available
HealthAid Strong Calcium 600mg chewable tablets
090501100BBDAAZ
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood No data available
Sandocal 400 effervescent tablets
090501100BBCAAC
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood No data available
Sandocal+D 1200 effervescent tablets
090501100BBFQA0
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood No data available
Solgar Chelated Calcium 166.67mg tablets
090501100BBBYA0
Proprietary compound preparation BNF 0905011 Other calcium supplement preparations Nutrition and Blood No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.